Pleiotropic actions of PPAR agonist: A potential therapeutic perspectives in the treatment of diabetic nephropathy

Journal Title: Innovations in Pharmaceuticals and Pharmacotherapy (IPP) - Year 2018, Vol 6, Issue 1

Abstract

Peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptor proteins that function as transcription factors regulating the expression of genes. PPARα activators reduce the quantities of available fatty acids for triglyceride-rich very low-density lipoprotein synthesis in the liver. PPARα binds to a diverse set of ligands, namely, arachidonic acid metabolites (prostaglandins and leukotrienes), plasticizers and synthetic fibrate drugs such as bezafibrate, fenofibrate, clofibrate, and gemfibrozil. PPARγ agonists may also have therapeutic utility in the treatment of other conditions such as atherosclerosis, inflammation, cancer, and diabetic nephropathy. PPARδ plays a role in lipid metabolism, cholesterol efflux, and adipogenesis. In particular, diabetes is associated with the activation of enzymes that directly liberate ROS, including NAD(P)H oxidase. PPARα is expressed in proximal tubules and medullary thick ascending limbs where it is thought to be involved in the regulation of protein-degradation systems through maintenance of ATP homeostasis, control of fatty acid β-oxidation, and regulation of cytochrome P450 in proximal tubules. PPARγ is predominantly expressed in medullary collecting ducts and pelvic urothelium, and the latter site is potentially important for the putative link between PPARγ agonists and transitional cell cancer. The third isoform of PPAR and PPARβ/δ is also ubiquitously expressed in the kidney, with the highest levels observed in the proximal straight tubule in renal cortex and medulla. The review focuses on pleiotropic actions of PPAR agonist.

Authors and Affiliations

Mr. Sajid Rasool Shaikh

Keywords

Related Articles

Development and evaluation of novel skin lightening preparation

Skin lightening creams are the products which work on skin by reducing a pigment called melanin in the skin. It also lightens naturally dark skin. In this research article various In-Vitro and In-Vivo studies are conduct...

Obesity management therapies

Obesity is prominently referred as a lifestyle disease that exhibits itself as one of the major health threat of this day. 65% of the world's population lives in developed countries where overweight and obesity kills mor...

Evaluation of cardioprotective activity of Woodfordia fruticosa flower extracts against doxorubicin induced cardiotoxicity

Woodfordia fruticosa (WF) flower extracts (Petroleum ether- PEWF; Chloroform - CHWF; Ethyl acetate- EAWF; Methanol- MEWF; Hydroalcohol - HAWF) was evaluated for the phytochemical contents using phytochemical screening an...

Prevalence of Pseudomonas aeruginosa in burns and the recent trend in antibiotic sensitivity pattern

A small critical review that affirms the omnipresence of Pseudomonas aeruginosa in burn infections worldwide that area localised on the strains screened and on their susceptibility to the antibiotics that determines the...

Isolated multidrug-resistant ESBL enterobacteriaceae strains in wounds are susceptible to amikacin

Enterobacteriaceae is a family of facultative aerobic bacteria thriving well in wounds that are prone to hospital borne infections infections, in specific post-operative wounds. Recent observations reflect the increased...

Download PDF file
  • EP ID EP570204
  • DOI -
  • Views 61
  • Downloads 0

How To Cite

Mr. Sajid Rasool Shaikh (2018). Pleiotropic actions of PPAR agonist: A potential therapeutic perspectives in the treatment of diabetic nephropathy. Innovations in Pharmaceuticals and Pharmacotherapy (IPP), 6(1), 6-12. https://europub.co.uk/articles/-A-570204